Preparation is crucial. Emergency situations, like #HurricaneDorian, can significantly impact everyone’s safety, but they can be especially upsetting and confusing for individuals living with #Alzheimers and other dementias. For more info, visit https://t.co/etWhMkUaPo. #ENDALZ
#NTRP notes an article highlighting the synaptic deficiency hypothesis was published online in @TrendsinPharma
Dr. Dan Alkon "Bryostatin uses #novel mechanism action to generate new, mature synaptic connections & prevent #neuronal death in #AD.
https://t.co/LCF1ixvs2h
I’m in @TheHill today with an open invitation for the 2020 presidential hopefuls: join me on a bus trip of hope. Let’s meet the scientists and researchers who work every day to get cures and treatments to the patients who need them. https://t.co/BR0L7HhX0j
CEO Dr. Charles Ryan on @nasdaq#TradeTalks today speaking to @jillmalandrino "Our goal is to provide a therapeutic to individuals who have #Alzheimer's disease in which they have an improvement in cognitive function."
https://t.co/MAiEUQHZ2a
Thank you @CogRx CEO Ken Moch for your @PittsburghPG op-ed warning policymakers in Washington will consider proposals threatening to stifle progress in #Alzheimers research.
https://t.co/GJF4ZXzxvJ
A powerful reminder to those of us who do not have #Alzheimers disease or another form of #dementia to continue seeing and focusing on the whole person, to support #disabilities while respecting and embracing abilities.
It's hard to overstate how important finding a better diagnostic is for fighting #Alzheimers. That’s why I’m investing in new ideas for easier and more accurate diagnosis of the disease. https://t.co/WM9phNmyJo
Please re-Tweet to raise awareness that it is time to shed the #prejudice of low expectations and embrace the potential for living fully with #Alzheimers disease and other forms of #dementia.
CEO Dr. Charles Ryan receiving @investacure#CureCoinAward on behalf of @Neurotrope1 founder Dr. Daniel Alkon. Dr. Alkon was honored during #AAIC for his work in developing #Bryostatin, a natural compound showing promise in restoring synaptic networks in the brain.
#Alzheimers
@Neurotrope1 Advisory Board Participates in KOL #Oppenheimer#Biotechnology Team Call. Friday July 19, 2019- 11 AM EST.
#Alzheimer's #Brain US/Canada (800) 344-0695, passcode 2687039
International (706) 679-5238, passcode 2687039